-
公开(公告)号:US10654821B2
公开(公告)日:2020-05-19
申请号:US16561459
申请日:2019-09-05
发明人: Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC分类号: C07D307/94 , C07D405/10 , C07D413/14 , C07D413/10 , C07D407/12
摘要: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.
-
公开(公告)号:US20200002302A1
公开(公告)日:2020-01-02
申请号:US16561459
申请日:2019-09-05
发明人: Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC分类号: C07D307/94 , C07D405/10 , C07D407/12 , C07D413/10 , C07D413/14
摘要: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.
-
公开(公告)号:US20230136988A1
公开(公告)日:2023-05-04
申请号:US18046270
申请日:2022-10-13
发明人: Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC分类号: C07D307/94 , C07D405/04 , C07D413/04 , A61K31/4155 , A61K31/4245 , A61K31/343 , C07D405/10 , C07D407/12 , C07D413/10 , C07D413/14
摘要: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.-
公开(公告)号:US11472784B2
公开(公告)日:2022-10-18
申请号:US17212373
申请日:2021-03-25
发明人: Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC分类号: C07D307/94 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/10 , C07D413/14 , A61K31/343 , A61K31/4155 , A61K31/4245
摘要: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.-
公开(公告)号:US11512067B2
公开(公告)日:2022-11-29
申请号:US16646130
申请日:2018-09-13
发明人: Toru Taniguchi , Osamu Iwamoto , Keiji Saito , Katsuyoshi Nakajima , Yasuyuki Ogawa , Nobuya Kurikawa , Seiko Nagata , Kaori Ito , Eriko Kioi
IPC分类号: C07D401/14 , C07D403/14 , C07D405/14 , C07D413/14 , C07D471/04 , C07D498/10
摘要: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: A: e.g., Benzene, E: e.g., —CH2—, G: e.g., a 5-membered aromatic heterocyclic ring, X: e.g., cyclohexane, J: e.g., a 5-membered aromatic heterocyclic ring, Y: e.g., a phenyl group, R1, R2, R3: e.g., a halogen atom, R4: e.g., a C1-C6 alkyl group, R5: e.g., a hydrogen atom, R6a, R6b, R6c, R6d: e.g., a hydrogen atom, R7: e.g., a hydrogen atom, R8: e.g., a hydrogen atom, n1, n2, n3: e.g., 1.-
公开(公告)号:US20210292292A1
公开(公告)日:2021-09-23
申请号:US17212373
申请日:2021-03-25
发明人: Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC分类号: C07D307/94 , C07D405/04 , C07D413/04 , A61K31/4155 , A61K31/4245 , A61K31/343 , C07D405/10 , C07D407/12 , C07D413/10 , C07D413/14
摘要: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.-
公开(公告)号:US10975052B2
公开(公告)日:2021-04-13
申请号:US16844621
申请日:2020-04-09
发明人: Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC分类号: C07D307/94 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/10 , C07D413/14 , A61K31/343 , A61K31/4155 , A61K31/4245
摘要: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.-
公开(公告)号:US12091395B2
公开(公告)日:2024-09-17
申请号:US18501481
申请日:2023-11-03
发明人: Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC分类号: C07D307/94 , A61K31/343 , A61K31/4155 , A61K31/4245 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/10 , C07D413/14
CPC分类号: C07D307/94 , A61K31/343 , A61K31/4155 , A61K31/4245 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/10 , C07D413/14
摘要: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof.
wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.-
公开(公告)号:US11834427B2
公开(公告)日:2023-12-05
申请号:US18046270
申请日:2022-10-13
发明人: Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC分类号: C07D307/94 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/14 , A61K31/343 , A61K31/4155 , A61K31/4245 , C07D413/10
CPC分类号: C07D307/94 , A61K31/343 , A61K31/4155 , A61K31/4245 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/10 , C07D413/14
摘要: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof.
wherein the symbols in the formula are defined below:
R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group;
A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.-
公开(公告)号:US20200347030A1
公开(公告)日:2020-11-05
申请号:US16646130
申请日:2018-09-13
发明人: Toru Taniguchi , Osamu Iwamoto , Keiji Saito , Katsuyoshi Nakajima , Yasuyuki Ogawa , Nobuya Kurikawa , Seiko Nagata , Kaori Ito , Eriko Kioi
IPC分类号: C07D401/14 , C07D403/14 , C07D471/04 , C07D405/14 , C07D413/14 , C07D498/10
摘要: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: A: e.g., Benzene, E: e.g., —CH2—, G: e.g., a 5-membered aromatic heterocyclic ring, X: e.g., cyclohexane, J: e.g., a 5-membered aromatic heterocyclic ring, Y: e.g., a phenyl group, R1, R2, R3: e.g., a halogen atom, R4: e.g., a C1-C6 alkyl group, R5: e.g., a hydrogen atom, R6a, R6b, R6c, R6d: e.g., a hydrogen atom, R7: e.g., a hydrogen atom, R8: e.g., a hydrogen atom, n1, n2, n3: e.g., 1.
-
-
-
-
-
-
-
-
-